← Eichor
Study identifier: NCT07123870 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Combined Intravenous-Inhalational Anesthesia (CIVIA) on Postoperative Recovery Patterns.

Condition: Postoperative Recovery · Inhalation Anesthesia · Total Intravenous Anesthesia  ·  Sponsor: Kocaeli City Hospital

PhasePhase 4
Planned participants210
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

This study was planned as a single-center, prospective, randomized trial. Adult patients undergoing elective spinal surgery lasting longer than three hours, performed in a neurosurgery operating room, will be evaluated. Patients managed with three different anesthesia methods currently used will be examined for recovery patterns: 1. Total intravenous anesthesia (TIVA), 2. TIVA Combined anesthesia with sevoflurane and intravenous agents (sevoflurane-CIVIA), 3. TIVA Combined anesthesia with desflurane and intravenous agents (desflurane-CIVIA). Recovery patterns include; extubation time, eye opening time, emergence agitation, postoperative nausia and vomiting and postoperative recovery unit discharge time.

This description comes directly from the study's public registry record.

Talk to the study team

Ahmet YUKSEK, MD  ·  05326580351  ·  mdayuksek@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Kocaeli City HospitalKocaeli, Izmıt, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07123870